MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ ? BillionToOne, Inc. , a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, ...
As of September 30, 2025, BillionToOne held approximately $195.2 million in cash and cash equivalents. The Company raised gross proceeds of $314.0 million from its IPO, which closed on November 7, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback